Second, the experiments further verified that mRNA levels of DRAXIN were increased in gliomas using laboratory brain tissue samples (Fig. 1D), and were also significantly higher in glioma cell lines, especially in A172 cells, compared to HA cell (Fig. 1E). The gene discussed is DRAXIN; the disease is central nervous system cancer.